Source: Annual Congress 2012 - Sarcoidosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A.D.M. Vorselaars, W.A. Wuyts, V.M.M. Vorselaars, P. Zanen, V.H. Deneer, M. Thomeer, J.C. Grutters (Nieuwegein, Utrecht, Netherlands; Leuven, Hasselt, Belgium). Methotrexate vs azathioprine in chronic sarcoidosis. Eur Respir J 2012; 40: Suppl. 56, 168

Member's Comments

Keihani Sina - 04.09.2012 04:10
thank you. that shed some valuable light on a condition that is guided by little evidence to assist therapy stategues.

Related content which might interest you: Azathioprine and low-dose prednisone in chronic pulmonary sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005 Efficacy and toxicity of azathioprine plus corticosteroids in 32 patients with chronic persistent sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004 Colchicine, prednisone versus no therapy in idiopathic pulmonary fibosis Source: Eur Respir J 2006; 28: Suppl. 50, 744s Year: 2006 Mycophenolate mofetil and azathioprine in chronic hypersensitivity pneumonitis Source: International Congress 2016 – Orphan diseases I Year: 2016 Therapy with low dose methotrexate plus diprospan in patient with recalcitrant recidivating sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 541s Year: 2006 Idiopathic pulmonary fibrosis: efficacy of complex immunosuppressive therapy by cyclophosphamide and corticosteroids Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009 High-doses glucocorticosteroid treatment in sarcoidosis patients Source: Eur Respir J 2007; 30: Suppl. 51, 118s Year: 2007 Combined cytotoxic treatment (methotrexate and cyclophosphamide) in association with prednisone in sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 713s Year: 2004 The course of COVID-19 in pulmonary sarcoidosis patients, receiving methotrexate Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021 A case series on the use of steroids and mycophenolate mofetil in idiopathic and heritable pulmonary veno-occlusive disease: is there a role for immunosuppression? Source: Eur Respir J, 57 (6) 2004354; 10.1183/13993003.04354-2020 Year: 2021 Exacerbations of idiopathic pulmonary fibrosis treated with corticosteroids and cyclophosphamide pulses Source: Eur Respir J 2011; 38: 1487-1489 Year: 2011 Combination treatment with nintedanib and prednisolone for patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018 Corticosteroid treatment in sarcoidosis Source: Eur Respir J 2006; 28: 627-636 Year: 2006 Comparison of prednisolone and budesonide in the treatment of pulmonary sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 80s Year: 2005 Combination of pentoxifylline and steroids in sarcoidosis treatment Source: Eur Respir J 2005; 26: Suppl. 49, 269s Year: 2005 Chronic beryllium disease: azathioprine as a possible alternative to corticosteroid treatment Source: Eur Respir J 2013; 41: 234-236 Year: 2013 Rituximab in the treatment of refractory pulmonary sarcoidosis Source: Eur Respir J 2014; 43: 1525-1528 Year: 2014 Cyclophosphamide in steroid-refractory hypersensitivity pneumonitis and non-classifiable interstitial lung disease Source: International Congress 2017 – Novel and old entities Year: 2017 Intravenous pulse doses of high-dose corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Infliximab: An effective rescue therapy in refractory extra-pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013